These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22996695)

  • 1. The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling.
    Su X; Floyd DH; Hughes A; Xiang J; Schneider JG; Uluckan O; Heller E; Deng H; Zou W; Craft CS; Wu K; Hirbe AC; Grabowska D; Eagleton MC; Townsley S; Collins L; Piwnica-Worms D; Steinberg TH; Novack DV; Conley PB; Hurchla MA; Rogers M; Weilbaecher KN
    J Clin Invest; 2012 Oct; 122(10):3579-92. PubMed ID: 22996695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clopidogrel-insensitive inducible pool of P2Y12 receptors contributes to thrombus formation: inhibition by elinogrel, a direct-acting, reversible P2Y12 antagonist.
    Haberstock-Debic H; Andre P; Mills S; Phillips DR; Conley PB
    J Pharmacol Exp Ther; 2011 Oct; 339(1):54-61. PubMed ID: 21730013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between P2RY12 gene polymorphisms and risks of clopidogrel resistance and adverse cardiovascular events after PCI in patients with acute coronary syndrome.
    Li M; Wang H; Xuan L; Shi X; Zhou T; Zhang N; Huang Y
    Medicine (Baltimore); 2017 Apr; 96(14):e6553. PubMed ID: 28383427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles and interactions among protease-activated receptors and P2ry12 in hemostasis and thrombosis.
    Cornelissen I; Palmer D; David T; Wilsbacher L; Concengco C; Conley P; Pandey A; Coughlin SR
    Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18605-10. PubMed ID: 20930120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractalkine activates a signal transduction pathway similar to P2Y12 and is associated with impaired clopidogrel responsiveness.
    Flierl U; Fraccarollo D; Lausenmeyer E; Rosenstock T; Schulz C; Massberg S; Bauersachs J; Schäfer A
    Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):1832-40. PubMed ID: 22652599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of P2Y12-dependent and -independent mechanisms of glycoprotein VI-mediated Rap1 activation in platelets.
    Larson MK; Chen H; Kahn ML; Taylor AM; Fabre JE; Mortensen RM; Conley PB; Parise LV
    Blood; 2003 Feb; 101(4):1409-15. PubMed ID: 12393417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADP-stimulated activation of Akt during integrin outside-in signaling promotes platelet spreading by inhibiting glycogen synthase kinase-3β.
    O'Brien KA; Gartner TK; Hay N; Du X
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2232-40. PubMed ID: 22814751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier.
    Lou N; Takano T; Pei Y; Xavier AL; Goldman SA; Nedergaard M
    Proc Natl Acad Sci U S A; 2016 Jan; 113(4):1074-9. PubMed ID: 26755608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RASA3 is a critical inhibitor of RAP1-dependent platelet activation.
    Stefanini L; Paul DS; Robledo RF; Chan ER; Getz TM; Campbell RA; Kechele DO; Casari C; Piatt R; Caron KM; Mackman N; Weyrich AS; Parrott MC; Boulaftali Y; Adams MD; Peters LL; Bergmeier W
    J Clin Invest; 2015 Apr; 125(4):1419-32. PubMed ID: 25705885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.
    Savi P; Herbert JM
    Semin Thromb Hemost; 2005 Apr; 31(2):174-83. PubMed ID: 15852221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A complementary role for tetraspanin superfamily member CD151 and ADP purinergic P2Y12 receptor in platelets.
    Makkawi M; Moheimani F; Alserihi R; Howells D; Wright M; Ashman L; Jackson DE
    Thromb Haemost; 2015 Nov; 114(5):1004-19. PubMed ID: 26245294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained activation of ADP/P2ry12 signaling induces SMC senescence contributing to thoracic aortic aneurysm/dissection.
    Zhang WM; Liu Y; Li TT; Piao CM; Liu O; Liu JL; Qi YF; Jia LX; Du J
    J Mol Cell Cardiol; 2016 Oct; 99():76-86. PubMed ID: 27534720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin complements G(i)- but not G(q)-dependent pathways for integrin {alpha}(IIb){beta}(3) activation and platelet aggregation.
    Campus F; Lova P; Bertoni A; Sinigaglia F; Balduini C; Torti M
    J Biol Chem; 2005 Jul; 280(26):24386-95. PubMed ID: 15863506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clopidogrel (Plavix), a P2Y12 receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo.
    Syberg S; Brandao-Burch A; Patel JJ; Hajjawi M; Arnett TR; Schwarz P; Jorgensen NR; Orriss IR
    J Bone Miner Res; 2012 Nov; 27(11):2373-86. PubMed ID: 22714653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced bone turnover in mice lacking the P2Y13 receptor of ADP.
    Wang N; Robaye B; Agrawal A; Skerry TM; Boeynaems JM; Gartland A
    Mol Endocrinol; 2012 Jan; 26(1):142-52. PubMed ID: 22108801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.
    Gareau AJ; Brien C; Gebremeskel S; Liwski RS; Johnston B; Bezuhly M
    Clin Exp Metastasis; 2018 Feb; 35(1-2):25-35. PubMed ID: 29322294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The platelet P2Y₁₂ receptor for adenosine diphosphate: congenital and drug-induced defects.
    Cattaneo M
    Blood; 2011 Feb; 117(7):2102-12. PubMed ID: 20966167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Rap1B by G(i) family members in platelets.
    Woulfe D; Jiang H; Mortensen R; Yang J; Brass LF
    J Biol Chem; 2002 Jun; 277(26):23382-90. PubMed ID: 11970953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A complementary role for tetraspanin superfamily member TSSC6 and ADP purinergic P2Y
    Makkawi M; Howells D; Wright MD; Jackson DE
    Thromb Res; 2018 Jan; 161():12-21. PubMed ID: 29178985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montelukast inhibits RANKL‑induced osteoclast formation and bone loss via CysLTR1 and P2Y12.
    Kang JH; Lim H; Lee DS; Yim M
    Mol Med Rep; 2018 Aug; 18(2):2387-2398. PubMed ID: 29916540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.